Zobrazeno 1 - 6 of 6 pro vyhledávání: '"Anthony McKinney"'
1
Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies
Autor: Eva Kohegyi, Timothy E. Wilens, Anthony McKinney, Timothy Wigal, Mary Hobart, Sharon B. Wigal, Jessica J Madera, Ross A. Baker
Publikováno v: Neuropsychiatric Disease and Treatment. 16:1411-1426
Purpose Two phase 2 studies evaluated the efficacy and tolerability of centanafadine sustained-release (SR) for adults with attention-deficit/hyperactivity disorder (ADHD). Patients and Methods In a phase 2a, flexible-dose, single-blind study, 41 mal
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::64bee169e4f041abd49d6867323a1c78
https://doi.org/10.2147/ndt.s242084
Zobrazit plný text záznamu
2
Amitifadine, a Triple Re-uptake Inhibitor, Reduces Self-administration of the Opiate Remifentanil in Rats
Autor: Corinne Wells, Caroline Pace, Alexander Vierling, John Modarres, Amir H. Rezvani, Zade Holloway, Graham Blair, Andrew B. Hawkey, Ashley Ko, Edward D. Levin, Anthony McKinney, Jed E. Rose
Publikováno v: Psychopharmacology (Berl)
RATIONALE: A variety of neural systems are involved in drug addiction, and some of these systems are shared across different addictive drugs. We have found several different types of drug treatments that successfully reduce nicotine self-administrati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b00adc79ee14ec832bcd10806863d8e6
https://europepmc.org/articles/PMC7244379/
Zobrazit plný text záznamu
3
Prolonging the Reduction of Nicotine Self-Administration in Rats by Coadministering Chronic Nicotine With Amitifadine, a Triple Monoamine Reuptake Inhibitor With CYP2B6 Inhibitory Actions
Autor: Anthony McKinney, Michelle E. Lee, Amir H. Rezvani, Corinne Wells, Susan Slade, Jed E. Rose, Edward D. Levin
Publikováno v: Nicotine Tob Res
Introduction Existing treatments can aid tobacco smoking cessation, but they have low efficacy. Because there is a network of neural systems involved in tobacco addiction, combination treatments may provide greater efficacy. Chronic nicotine and amit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a03b9d629cc27302f8c249e813db82d
https://europepmc.org/articles/PMC7297093/
Zobrazit plný text záznamu
6
Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial
Autor: Pál Czobor, Maurizio Fava, N.Y. Huang, Phil Skolnick, Pierre Tran, Mark Bradshaw, Anthony McKinney
Publikováno v: Journal of Psychiatric Research. (1):64-71
Amitifadine (EB-1010, formerly DOV 21,947) is a serotonin-preferring triple reuptake inhibitor with a relative potency to inhibit serotonin, norepinephrine, and dopamine uptake of ∼1:2:8, respectively. This 6-week, multicenter, randomized, double-b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fc492219f182be97383221920b6418c
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje